Cited by 6,552Cardiac pacing and defibrillation studiesHeart Failure Treatment and ManagementCardiac Health and Mental Health

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure

Open access

Bardy, Gust H., Lee, Kerry L., Mark, Daniel B., Poole, Jeanne E., Packer, Douglas L., Boineau, Robin, Domanski, Michael, Troutman, Charles, Anderson, Jill, Johnson, George, McNulty, Steven E., Clapp-Channing, Nancy, Davidson-Ray, Linda D., Fraulo, Elizabeth S., Fishbein, Daniel P., Luceri, Richard M., Ip, John H.·2005·New England Journal of Medicine

DOI 10.1056/nejmoa043399

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Sudden death from cardiac causes remains a leading cause of death among patients with congestive heart failure (CHF). Treatment with amiodarone or an implantable cardioverter-defibrillator (ICD) has been proposed to improve the prognosis in such patients. METHODS: We randomly assigned 2521 patients with New York Heart Association (NYHA) class II or III CHF and a left ventricular ejection fraction (LVEF) of 35 percent or less to conventional therapy for CHF plus placebo (847 patients), conventional therapy plus amiodarone (845 patients), or conventional therapy plus a conservatively programmed, shock-only, single-lead ICD (829 patients). Placebo and amiodarone were administered in a double-blind fashion. The primary end point was death from any cause. RESULTS: The median LVEF in patients was 25 percent; 70 percent were in NYHA class II, and 30 percent were in class III CHF. The cause of CHF was ischemic in 52 percent and nonischemic in 48 percent. The median follow-up was 45.5 months. There were 244 deaths (29 percent) in the placebo group, 240 (28 percent) in the amiodarone group, and 182 (22 percent) in the ICD group. As compared with placebo, amiodarone was associated with a similar risk of death (hazard ratio, 1.06; 97.5 percent confidence interval, 0.86 to 1.30; P=0.53) and ICD therapy was associated with a decreased risk of death of 23 percent (0.77; 97.5 percent confidence interval, 0.62 to 0.96; P=0.007) and an absolute decrease in mortality of 7.2 percentage points after five years in the overall population. Results did not vary according to either ischemic or nonischemic causes of CHF, but they did vary according to the NYHA class. CONCLUSIONS: In patients with NYHA class II or III CHF and LVEF of 35 percent or less, amiodarone has no favorable effect on survival, whereas single-lead, shock-only ICD therapy reduces overall mortality by 23 percent.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejmoa043399

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer series in statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,239
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
The Statistical Analysis of Failure Time Data.
Aitkin, M. A., Kalbfleisch, J. D., & Prentice, R. L. (1981) · Biometrics · doi:10.2307/2530581 · Cited by 9,875
Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction
Moss, A. J., Zaręba, W., Hall, W. J., Klein, H., Wilber, D. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Brown, M. W., & Andrews, M. L. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013474 · Cited by 6,885
Improved Survival with an Implanted Defibrillator in Patients with Coronary Disease at High Risk for Ventricular Arrhythmia
Moss, A. J., Hall, W. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Klein, H., Levine, J. H., Saksena, S., Waldo, A. L., Wilber, D., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612263352601 · Cited by 4,165
A Multiple Testing Procedure for Clinical Trials
O'Brien, P. C., & Fleming, T. R. (1979) · Biometrics · doi:10.2307/2530245 · Cited by 3,311
A Comparison of Antiarrhythmic-Drug Therapy with Implantable Defibrillators in Patients Resuscitated from Near-Fatal Ventricular Arrhythmias
The AVID Investigators (1997) · New England Journal of Medicine · doi:10.1056/nejm199711273372202 · Cited by 3,221
The Statistical Analysis of Failure Time Data
Kalbfleisch, J. D., & Prentice, R. L. (2002) · Wiley Series in Probability and Statistics · doi:10.1002/9781118032985 · Cited by 3,219
Discrete sequential boundaries for clinical trials
GORDON LAN, K. K., & DEMETS, D. L. (1983) · Biometrika · doi:10.1093/biomet/70.3.659 · Cited by 2,310

Show all 20 references

Research works printed but not linked: 1

10.2307/2281868 · DOI · Paper page

Sorted by citations

Items 701–800 of 1,019

Rationale and design of a randomized controlled trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with asymptomatic left ventricular dysfunction with previous symptoms or mild heart failure—the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study
Linde, C. M., Gold, M. R., Abraham, W. T., & Daubert, J. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.03.002 · Cited by 86
Disparities in the Use of Primary Prevention and Defibrillator Therapy Among Blacks and Women
Gauri, A. J., Davis, A. M., Hong, T. E., Burke, M. C., & Knight, B. P. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.08.021 · Cited by 83
Improvement in Structural and Functional Echocardiographic Parameters During Chronic Heart Failure Therapy Guided by Natriuretic Peptides: Mechanistic Insights from the ProBNP Outpatient Tailored Chronic Heart Failure (PROTECT) Study
Weiner, R. B., Baggish, A. L., Chen‐Tournoux, A., Marshall, J. E., Gaggin, H. K., Bhardwaj, A., Mohammed, A. A., Rehman, S., Barajas, L. J., Barajas, J. A., et al. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs180 · Cited by 84
Improving survival in the 6 months after diagnosis of heart failure in the past decade: population-based data from the UK
Mehta, P. A., Dubrey, S. W., McIntyre, H. F., Walker, D. M., Hardman, S. M. C., Sutton, G. C., McDonagh, T., & Cowie, M. (2009) · Heart · doi:10.1136/hrt.2008.156034 · Cited by 83
Lifetime cost-effectiveness of prophylactic implantation of a cardioverter defibrillator in patients with reduced left ventricular systolic function: results of Markov modelling in a European population
Cowie, M., Marshall, D. A., Drummond, M., Ferko, N. C., Maschio, M., Ekman, M., Roy, L. D., Heidbüchel, H., Verboven, Y., Braunschweig, F., et al. (2009) · EP Europace · doi:10.1093/europace/eup068 · Cited by 83
Automatic home monitoring of implantable cardioverter defibrillators
Nielsen, J. C., Kottkamp, H., Zabel, M., Aliot, E., Kreutzer, U., Bauer, A., Schuchert, A., Neuser, H., Schumacher, B., Schmidinger, H., et al. (2008) · EP Europace · doi:10.1093/europace/eun099 · Cited by 84
Effects of implantable cardioverter/defibrillator shock and antitachycardia pacing on anxiety and quality of life: A MADIT-RIT substudy
Perini, A. P., Kutyifa, V., Veazie, P. J., Daubert, J. P., Schuger, C. D., Zaręba, W., McNitt, S. A., Rosero, S. Z., TOMPKINS, C. M., Padeletti, L., et al. (2017) · American Heart Journal · doi:10.1016/j.ahj.2017.03.009 · Cited by 83
Outcomes of Cardiac Resynchronization Therapy With or Without Defibrillation in Patients With Nonischemic Cardiomyopathy
Leyva, F., Zegard, A., Acquaye, E., Gubran, C., Taylor, R. J., Foley, P. W. X., Umar, F., Patel, K., Panting, J. R., Marshall, H. J., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.07.712 · Cited by 83
Sudden cardiac death in dialysis patients: different causes and management strategies
Genovesi, S., Boriani, G., Covic, A. C., Vernooij, R. W. M., Combe, C., Burlacu, A., Davenport, A., Kanbay, M., Kirmizis, D. A., Schneditz, D., et al. (2019) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfz182 · Cited by 83
Full-Body MRI in Patients With an Implantable Cardioverter-Defibrillator
Gold, M. R., Sommer, T., Schwitter, J., Fagih, A. R. A., Albert, T. S. E., Merkely, B. P., PETERSON, M. W., Ciuffo, A., Lee, S., Landborg, L., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.04.047 · Cited by 83
Intravascular Device Infections
Gandelman, G., Frishman, W. H., Wiese, C., Gastwirth, V., Hong, S. Y., Aronow, W. S., & Horowitz, H. W. (2006) · Cardiology in Review · doi:10.1097/01.crd.0000197966.53529.67 · Cited by 83
QRS Fragmentation and the Risk of Sudden Cardiac Death in MADIT II
brenyo, A. J., Pietrasik, G. M., Barsheshet, A., Huang, D. T.-C., Polonsky, B., McNitt, S. A., Moss, A. J., & Zaręba, W. (2012) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2012.02390.x · Cited by 83
Fundamental Differences in Electrophysiologic and Electroanatomic Substrate Between Ischemic Cardiomyopathy Patients With and Without Clinical Ventricular Tachycardia
Haqqani, H. M., Kalman, J. M., Roberts‐Thomson, K. C., Balasubramaniam, R., Rosso, R., SNOWDON, R. L., SPARKS, P. B., Vohra, J. K., & Morton, J. B. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.024 · Cited by 83
Mechanisms of Sudden Cardiac Death in Myocardial Infarction Survivors
Bunch, T. J., Hohnloser, S. H., & Gersh, B. J. (2007) · Circulation · doi:10.1161/circulationaha.106.683235 · Cited by 83
Implantable cardioverter-defibrillators in the elderly: rationale and specific age-related considerations
Barra, S., Providencia, R. A., Paiva, L., Heck, P., & Agarwal, S. (2014) · EP Europace · doi:10.1093/europace/euu296 · Cited by 83
The Implantable Cardioverter‐Defibrillator Lead: Principles, Progress, and Promises
Haqqani, H. M., & Mond, H. G. (2009) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2009.02492.x · Cited by 83
Cardiovascular pharmacogenomics and individualized drug therapy
Pereira, N. L., & Weinshilboum, R. M. (2009) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2009.154 · Cited by 72
Acute and 3-Month Performance of a Communicating Leadless Antitachycardia Pacemaker and Subcutaneous Implantable Defibrillator
Tjong, F. V. Y., Brouwer, T. F., Koop, B. E., Soltis, B., Shuros, A. C., Schmidt, B. L., Swackhamer, B., Quast, A. B. E., Wilde, A. A. M., Burke, M. C., et al. (2017) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2017.04.002 · Cited by 82
Recurrent Implantable Cardioverter-Defibrillator Replacement Is Associated with an Increasing Risk of Pocket-Related Complications
Borleffs, C. J. W., Thijssen, J., de Bie, M. K., van Rees, J. B., van Welsenes, G. H., van Erven, L., Bax, J. J., Cannegieter, S. C., & Schalij, M. J. (2010) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2010.02780.x · Cited by 82
Depression and Anxiety Symptoms Are Associated With Reduced Dietary Adherence in Heart Failure Patients Treated With an Implantable Cardioverter Defibrillator
Luyster, F. S., Hughes, J. W., & Gunstad, J. (2009) · The Journal of Cardiovascular Nursing · doi:10.1097/01.jcn.0000317469.63886.24 · Cited by 83
Statin use was associated with reduced mortality in both ischemic and nonischemic cardiomyopathy and in patients with implantable defibrillators: Mortality data and mechanistic insights from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)
Dickinson, M. G., Ip, J. E., Olshansky, B., Hellkamp, A. S., Anderson, J., Poole, J. E., Mark, D. B., Lee, K. L., & Bardy, G. H. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.02.002 · Cited by 82
Self-citation
The clinical course of patients with implantable cardioverter-defibrillators: Extended experience on clinical outcome, device replacements, and device-related complications
van der Heijden, A. C., Borleffs, C. J. W., Buiten, M. S., Thijssen, J., van Rees, J. B., Cannegieter, S. C., Schalij, M. J., & van Erven, L. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.02.035 · Cited by 82
Prediction of Life-Threatening Arrhythmic Events in Patients With Chronic Myocardial Infarction by Contrast-Enhanced CMR
Boyé, P., Abdel‐Aty, H., Zacharzowsky, U. B., Bohl, S., Schwenke, C., van der Geest, R. J., Dietz, R., Schirdewan, A., & Schulz‐Menger, J. (2011) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2011.04.014 · Cited by 80
Adverse reactions of Amiodarone.
Biancatelli, R. M. L. C., Congedo, V., Calvosa, L., Ciacciarelli, M., Polidoro, A., & Iuliano, L. (2019) · Europe PMC (PubMed Central) · doi:10.11909/j.issn.1671-5411.2019.07.004 · Cited by 81
Diretriz da SBC sobre Diagnóstico e Tratamento de Pacientes com Cardiomiopatia da Doença de Chagas – 2023
Marin‐Neto, J. A., Rassi, A., de Oliveira, G. M. M., Correia, L. C. L., Ramos, A. N., Luquetti, A. O., Hasslocher‐Moreno, A. M., de Sousa, A. S., de Paola, Â. A. V., Sousa, A. C. S., et al. (2023) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20230269 · Cited by 103
Important Differences in Mode of Death Between Men and Women With Heart Failure Who Would Qualify for a Primary Prevention Implantable Cardioverter-Defibrillator
Rho, R. W., Patton, K. K., Poole, J. E., Cleland, J. G. F., Shadman, R., Anand, I. S., Maggioni, A. P., Carson, P. E., Swedberg, K. B., & Levy, W. C. (2012) · Circulation · doi:10.1161/circulationaha.111.069245 · Cited by 79
Self-citation
Predicting early mortality after implantable defibrillator implantation: A clinical risk score for optimal patient selection
Parkash, R., Stevenson, W. G., Epstein, L. M., & Maisel, W. H. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.04.009 · Cited by 81
Prevention of inappropriate therapy in implantable defibrillators: A meta-analysis of clinical trials comparing single-chamber and dual-chamber arrhythmia discrimination algorithms
Theuns, D. A. M. J., Rivero‐Ayerza, M., Boersma, E., & Jordaens, L. J. L. M. (2007) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.02.041 · Cited by 81
Bias associated with left ventricular quantification by multimodality imaging: a systematic review and meta-analysis
Rigolli, M., Anandabaskaran, S., Christiansen, J., & WHALLEY, G. A. (2016) · Open Heart · doi:10.1136/openhrt-2015-000388 · Cited by 81
Cardiac contractility modulation: a novel approach for the treatment of heart failure
ABI‐SAMRA, F. M., & Gutterman, D. D. (2016) · Heart Failure Reviews · doi:10.1007/s10741-016-9571-6 · Cited by 84
Pre-implantation implantable cardioverter defibrillator concerns and Type D personality increase the risk of mortality in patients with an implantable cardioverter defibrillator
Pedersen, S. S., van den Broek, K. C., Erdman, R. A. M., Jordaens, L. J. L. M., & Theuns, D. A. M. J. (2010) · EP Europace · doi:10.1093/europace/euq296 · Cited by 80
Perspective: A dynamics-based classification of ventricular arrhythmias
Weiss, J. N., Garfinkel, A., Karagueuzian, H. S., Nguyen, T. P., Olcese, R., Chen, P., & Qu, Z. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.02.017 · Cited by 80
Infection and mortality after implantation of a subcutaneous ICD after transvenous ICD extraction
Boersma, L. V. A., Burke, M. C., Neužil, P., Lambiase, P. D., Friehling, T. D., Theuns, D. A. M. J., Garcia, F. C., Carter, N., Stivland, T. M., & Weiss, R. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.08.039 · Cited by 80
Current treatment options in (peri)myocarditis and inflammatory cardiomyopathy
Maisch, B., & Pankuweit, S. (2012) · Herz · doi:10.1007/s00059-012-3679-9 · Cited by 81
Survival in octogenarians receiving implantable defibrillators
Koplan, B. A., Epstein, L. M., Albert, C. M., & Stevenson, W. G. (2006) · American Heart Journal · doi:10.1016/j.ahj.2006.06.008 · Cited by 80
The Heart Failure Survival Score outperforms the peak oxygen consumption for heart transplantation selection in the era of device therapy
Goda, A., Lund, L. H., & MANCINI, D. M. (2010) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2010.09.007 · Cited by 80
B-type natriuretic peptide is a major predictor of ventricular tachyarrhythmias
Levine, Y. C., Rosenberg, M. A., Mittleman, M. A., Samuel, M., Methachittiphan, N., Link, M. S., Josephson, M. E., & Buxton, A. E. (2014) · Heart Rhythm · doi:10.1016/j.hrthm.2014.04.024 · Cited by 80
Type-D personality but not implantable cardioverter-defibrillator indication is associated with impaired health-related quality of life 3 months post-implantation
Pedersen, S. S., Theuns, D. A. M. J., Muskens, A. J. Q. M., Erdman, R. A. M., & Jordaens, L. J. L. M. (2007) · EP Europace · doi:10.1093/europace/eum041 · Cited by 80
Benefits and Risks of Long-term Amiodarone Therapy for Persistent Atrial Fibrillation: A Meta-analysis
Doyle, J. F., & Ho, K. M. (2009) · Mayo Clinic Proceedings · doi:10.4065/84.3.234 · Cited by 79
Not Everyone With an Ejection Fraction ≤30% Should Receive an ICD
Buxton, A. E. (2005) · Circulation · doi:10.1161/01.cir.0000165057.88551.2c · Cited by 80
Cardiac device infections are associated with a significant mortality risk
de Bie, M. K., van Rees, J. B., Thijssen, J., Borleffs, C. J. W., Trines, S. A. I. P., Cannegieter, S. C., Schalij, M. J., & van Erven, L. (2011) · Heart Rhythm · doi:10.1016/j.hrthm.2011.10.034 · Cited by 81
Cardiac Implantable Electronic Devices
Al‐Khatib, S. M. (2024) · New England Journal of Medicine · doi:10.1056/nejmra2308353 · Cited by 78
Role of CMR Imaging in Risk Stratification for Sudden Cardiac Death
AlJaroudi, W., Flamm, S. D., Saliba, W. I., Wilkoff, B. L., & Kwon, D. H. (2013) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2012.11.011 · Cited by 79
Registro Español de Desfibrilador Automático Implantable. V Informe Oficial del Grupo de Trabajo de Desfibrilador Automático Implantable de la Sociedad Española de Cardiología (2008)
Peinado, R., Torrecilla, E. G., Ormaetxe, J. M., Álvarez, M., León, R. C., & Alzueta, J. (2009) · Revista Española de Cardiología · doi:10.1016/s0300-8932(09)73128-8 · Cited by 80
Sudden cardiac death in China: current status and future perspectives
Zhang, S. (2015) · EP Europace · doi:10.1093/europace/euv143 · Cited by 79
Management of acute decompensated heart failure
Allen, L. A., & O'Connor, C. M. (2007) · Canadian Medical Association Journal · doi:10.1503/cmaj.051620 · Cited by 80
Hemodynamic Goals Are Relevant
Stevenson, L. W. (2006) · Circulation · doi:10.1161/circulationaha.104.478321 · Cited by 79
Preserved heart rate variability identifies low-risk patients with nonischemic dilated cardiomyopathy: Results from the DEFINITE trial
Rashba, E. J., Estes, N. A. M., Wang, P., Schaechter, A., Howard, A., Zareba, W., Couderc, J.-P., Perkiomaki, J., Levine, J., & Kadish, A. (2006) · Heart Rhythm · doi:10.1016/j.hrthm.2005.11.028 · Cited by 78
Ventricular Repolarization Dynamicity Provides Independent Prognostic Information Toward Major Arrhythmic Events in Patients With Idiopathic Dilated Cardiomyopathy
Iacoviello, M., Forleo, C., Guida, P., Romito, R., Sorgente, A., Sorrentino, S., Catucci, S., Mastropasqua, F., & Pitzalis, M. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.02.071 · Cited by 78
Effect of Cardiac Resynchronization Therapy on the Risk of First and Recurrent Ventricular Tachyarrhythmic Events in MADIT-CRT
Ouellet, G. M., Huang, D. T.-C., Moss, A. J., Hall, W. J., Barsheshet, A., McNitt, S. A., Klein, H., Zaręba, W., & Goldenberg, I. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.05.057 · Cited by 78
Prognostic Importance of Atrial Fibrillation in Implantable Cardioverter-Defibrillator Patients
Borleffs, C. J. W., van Rees, J. B., van Welsenes, G. H., van der Velde, E. T., van Erven, L., Bax, J. J., & Schalij, M. J. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.09.053 · Cited by 76
Risks and Challenges of Implantable Cardioverter-Defibrillators in Young Adults
Sherrid, M. V., & Daubert, J. P. (2008) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2008.10.001 · Cited by 78
How Can Optimization of Medical Treatment Avoid Unnecessary Implantable Cardioverter-Defibrillator Implantations in Patients With Idiopathic Dilated Cardiomyopathy Presenting With “SCD-HeFT Criteria?”
Zecchin, M., Merlo, M., Pivetta, A., Barbati, G., Lutman, C., Gregori, D., Serdoz, L. V., Bardari, S., Magnani, S., Lenarda, A. D., et al. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.10.033 · Cited by 78
Racial Disparity in the Utilization of Implantable-Cardioverter Defibrillators Among Patients With Prior Myocardial Infarction and an Ejection Fraction of ≤35%
Thomas, K. L., Al‐Khatib, S. M., Kelsey, R. C., Bush, H., Brosius, L., Velazquez, E. J., Peterson, E. D., & Gilliam, F. R. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.04.024 · Cited by 78
Clinical Management and Prevention of Sudden Cardiac Death
Yousuf, O. K., Chrispin, J., Tomaselli, G. F., & Berger, R. D. (2015) · Circulation Research · doi:10.1161/circresaha.116.304555 · Cited by 83
Understanding Heart Failure
Mazurek, J. A., & Jessup, M. L. (2015) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2015.08.001 · Cited by 78
Risk Stratification for Sudden Cardiac Death in Non-Ischaemic Dilated Cardiomyopathy
Akhtar, M. M., & Elliot, P. M. (2019) · Current Cardiology Reports · doi:10.1007/s11886-019-1236-3 · Cited by 77
Atrial Fibrillation–Mediated Cardiomyopathy
Qin, D., MANSOUR, M. C., Ruskin, J. N., & Heist, E. K. (2019) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.119.007809 · Cited by 78
The Role of Echocardiography in Heart Failure
Marwick, T. H. (2015) · Journal of Nuclear Medicine · doi:10.2967/jnumed.114.150433 · Cited by 79
Long-term survival after successful inhospital cardiac arrest resuscitation
Bloom, H. L., Shukrullah, I., Cuellar, J. G., Lloyd, M. S., Dudley, S. C., & Zafari, A. M. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.02.011 · Cited by 77
Review of the Registry's Second Year, Data Collected, and Plans to Add Lead and Pediatric ICD Procedures
Hammill, S. C., Kremers, M. S., Stevenson, L. W., Kadish, A. H., Heidenreich, P. A., Lindsay, B. D., Mirro, M. J., Radford, M. J., Wang, Y., Curtis, J. P., et al. (2008) · Heart Rhythm · doi:10.1016/j.hrthm.2008.07.015 · Cited by 76
Real-time integration of 2D intracardiac echocardiography and 3D electroanatomical mapping to guide ventricular tachycardia ablation
Khaykin, Y., Skanes, A. C., Whaley, B., Hill, C., Beardsall, M., Seabrook, C., Wulffhart, Z. A., Oosthuizen, R., Gula, L. J., & Verma, A. (2008) · Heart Rhythm · doi:10.1016/j.hrthm.2008.06.025 · Cited by 77
Making Decisions About Implantable Cardioverter-Defibrillators from Implantation to End of Life: An Integrative Review of Patients’ Perspectives
Lewis, K. B., Stacey, D., & Matlock, D. D. (2014) · Patient · doi:10.1007/s40271-014-0055-2 · Cited by 77
Exercise training and cardiac rehabilitation in patients with implantable cardioverter defibrillators: a review of current literature focusing on safety, effects of exercise training, and the psychological impact of programme participation
Isaksen, K., Morken, I. M., Munk, P. S., & Larsen, A. I. (2011) · European Journal of Preventive Cardiology · doi:10.1177/1741826711414624 · Cited by 77
Transvenous Implantable Cardioverter‐Defibrillator (ICD) Lead Performance: A Meta‐Analysis of Observational Studies
Providencia, R. A., Kramer, D. B., Pimenta, D., Babu, G. G., Hatfield, L. A., Ioannou, A., Novak, J., Hauser, R. G., & Lambiase, P. D. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.002418 · Cited by 77
Use of Guideline-Directed Medications for Heart Failure Before Cardioverter-Defibrillator Implantation
Roth, G. A., Poole, J. E., Zaha, R. L., Zhou, W., Skinner, J., & Morden, N. E. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.12.046 · Cited by 77
Self-citation
Sudden Cardiac Arrest Risk Assessment
Myerburg, R. J., & Goldberger, J. J. (2017) · JAMA Cardiology · doi:10.1001/jamacardio.2017.0266 · Cited by 79
Korean Guidelines for Diagnosis and Management of Chronic Heart Failure
Kim, M., Lee, J., Kim, E. J., Park, D.-G., Park, S., Park, J. J., Shin, M., Yoo, B., Youn, J., Lee, S. E., et al. (2017) · Korean Circulation Journal · doi:10.4070/kcj.2017.0009 · Cited by 76
Premature Ventricular Complex-induced Cardiomyopathy
González‐Panizo, J., & Barra, S. (2018) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2018.23.2 · Cited by 76
Predictors of long-term mortality in Multicenter Automatic Defibrillator Implantation Trial II (MADIT II) patients with implantable cardioverter-defibrillators
Cygankiewicz, I., Gillespie, J. A., Zaręba, W., Brown, M. W., Goldenberg, I., Klein, H., McNitt, S. A., Polonsky, S., Andrews, M. L., Dwyer, E. M., et al. (2008) · Heart Rhythm · doi:10.1016/j.hrthm.2008.12.023 · Cited by 76
Fragmented QRS and Mortality Risk in Patients With Left Ventricular Dysfunction
Cheema, A., Khalid, A., Wimmer, A. P., Bartone, C. L., Chow, T., Spertus, J. A., & Chan, P. S. (2010) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.110.940478 · Cited by 76
Cardiac sympatho-vagal balance and ventricular arrhythmia
Kalla, M., Herring, N., & Paterson, D. J. (2016) · Autonomic Neuroscience · doi:10.1016/j.autneu.2016.08.016 · Cited by 78
Association of Implantable Cardioverter Defibrillators With Survival in Patients With and Without Improved Ejection Fraction
Adabağ, S., Patton, K. K., Buxton, A. E., Rector, T. S., Ensrud, K. E., Vakil, K. P., Levy, W. C., & Poole, J. E. (2017) · JAMA Cardiology · doi:10.1001/jamacardio.2017.1413 · Cited by 76
Self-citation
Defibrillation for Ventricular Fibrillation
Nichol, G., Sayre, M. R., Guerra, F., & Poole, J. E. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.07.778 · Cited by 76
Self-citation
How robust are clinical trials in heart failure?
Docherty, K. F., Campbell, R. T., Jhund, P. S., Petrie, M. C., & McMurray, J. J. V. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw427 · Cited by 75
2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure
Heidenreich, P. A., Fonarow, G. C., Breathett, K. K., Jurgens, C. Y., Pisani, B., Pozehl, B., Spertus, J. A., Taylor, K. G., Thibodeau, J. T., Yancy, C. W., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.07.023 · Cited by 83
Cardiac magnetic resonance imaging: infarct size is an independent predictor of mortality in patients with coronary artery disease
Bello, D. B., Einhorn, A., Kaushal, R., Kenchaiah, S., Raney, A. R., Fieno, D. S., Narula, J., Goldberger, J. J., Shivkumar, K., Subacius, H. P., et al. (2010) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2010.03.031 · Cited by 75
Trajectory of End-Stage Heart Failure: The Influence of Technology and Implications for Policy Change
Goldstein, N. E., & Lynn, J. (2006) · Perspectives in biology and medicine · doi:10.1353/pbm.2006.0008 · Cited by 75
Selecting Patients for Discussion of the ICD as Primary Prevention for Sudden Death in Heart Failure
Stevenson, L. W., & Desai, A. S. (2006) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2006.06.001 · Cited by 75
Candidate Selection for Long-term Left Ventricular Assist Device Therapy for Refractory Heart Failure
Miller, L. W., & Lietz, K. (2006) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2006.03.007 · Cited by 75
Addendum to “Personal and Public Safety Issues Related to Arrhythmias That May Affect Consciousness: Implications for Regulation and Physician Recommendations: A Medical/ Scientific Statement From the American Heart Association and the North American Society of Pacing and Electrophysiology” Public Safety Issues in Patients With Implantable Defibrillators A Scientific Statement From the American Heart Association and the Heart Rhythm Society
Epstein, A. E., Baessler, C. A., Curtis, A. B., Estes, N. A. M., Gersh, B. J., Grubb, B. P., & Mitchell, L. B. (2007) · Circulation · doi:10.1161/circulationaha.106.180203 · Cited by 75
Predictors of VT/VF-occurrence in ICD patients: results from the PROFIT-Study
Klein, G. G., Lissel, C., Fuchs, A.-C., Gardiwal, A., Oswald, H., deSousa, M., Pichlmaier, A. M., Lichtinghagen, R., Geerlings, H., Lippolt, P., et al. (2006) · EP Europace · doi:10.1093/europace/eul082 · Cited by 75
Implantable cardioverter defibrillators and Chagas' disease: results of the ICD Registry Latin America
Muratore, C. A., Sa, L. A. B., Chiale, P. A., Eloy, R., TENTORI, M. C., Escudero, J., Lima, A. M. C., Medina, L. E., GARILLO, R. N., & Maloney, J. (2008) · EP Europace · doi:10.1093/europace/eun325 · Cited by 75
Determinants and outcome of amiodarone-associated thyroid dysfunction: Thyroid dysfunction and oral amiodarone therapy
Ahmed, S., Van Gelder, I. C., Wiesfeld, A. C. P., Van Veldhuisen, D. J., & Links, T. P. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04087.x · Cited by 72
Clinical Experience of Subcutaneous and Transvenous Implantable Cardioverter Defibrillators in Children and Teenagers
Pettit, S., McLean, A. D., Colquhoun, I. W., Connelly, D. T., & McLEOD, K. A. (2013) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.12233 · Cited by 74
Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure: systematic review and economic evaluation
Colquitt, J. L., Mendes, D., Clegg, A. J., Harris, P., Cooper, K., Picot, J., & Bryant, J. (2014) · Health Technology Assessment · doi:10.3310/hta18560 · Cited by 75
Contemporary strategies for risk stratification and prevention of sudden death with the implantable defibrillator in hypertrophic cardiomyopathy
Maron, B. J., & Maron, M. S. (2016) · Heart Rhythm · doi:10.1016/j.hrthm.2015.12.048 · Cited by 74
Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force
Görenek, B., Lundqvist, C. B., Brugada, J., Camm, A. J., Hindricks, G., Huber, K., Kirchhof, P. F., Kück, K., Kudaiberdieva, G., Lin, T., et al. (2015) · EuroIntervention · doi:10.4244/eijy14m08_19 · Cited by 74
Long-Term Follow-Up of DANISH (The Danish Study to Assess the Efficacy of ICDs in Patients With Nonischemic Systolic Heart Failure on Mortality)
Yafasova, A., Butt, J. H., Elming, M. B., Nielsen, J. C., Haarbo, J., Videbæk, L., Olesen, L. L., Steffensen, F. H., Bruun, N. E., Eiskjær, H., et al. (2021) · Circulation · doi:10.1161/circulationaha.121.056072 · Cited by 74
Multicenter experience with failed and recalled implantable cardioverter-defibrillator pulse generators
Hauser, R. G., Hayes, D. L., Epstein, A. E., Cannom, D. S., Vlay, S. C., SONG, S. L., & Tyers, G. F. O. (2006) · Heart Rhythm · doi:10.1016/j.hrthm.2006.02.011 · Cited by 74
Relation of left-ventricular dyssynchrony by phase analysis of gated SPECT images and cardiovascular events in patients with implantable cardiac defibrillators
AlJaroudi, W., Hage, F. G., Hermann, D., Doppalapudi, H., Venkataraman, R., Heo, J., & Iskandrian, A. E. (2010) · Journal of Nuclear Cardiology · doi:10.1007/s12350-009-9169-7 · Cited by 74
Implanted Cardiac Defibrillator Care in Radiation Oncology Patient Population
Gelblum, D. Y., & Amols, H. I. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.06.1903 · Cited by 74
Renal dialysis as a risk factor for appropriate therapies and mortality in implantable cardioverter-defibrillator recipients
Robin, J. C., Weinberg, K. M., Tiongson, J. E., Carnethon, M. R., Reddy, M., Ciaccio, C. E., Quadrini, M., Hsu, J. C., Fan, J. S., Choi, P., et al. (2006) · Heart Rhythm · doi:10.1016/j.hrthm.2006.06.013 · Cited by 74
Sex differences in outcomes of primary prevention implantable cardioverter-defibrillator therapy: combined registry data from eleven European countries
Sticherling, C., Arendacká, B., Svendsen, J. H., Wijers, S. C., Friede, T., Stockinger, J., Dommasch, M., Merkely, B. P., Willems, R., Lubiński, A., et al. (2017) · EP Europace · doi:10.1093/europace/eux176 · Cited by 78
Clinical Course and Quality of Life in High-Risk Patients With Hypertrophic Cardiomyopathy and Implantable Cardioverter-Defibrillators
Maron, B. J., Casey, S. A., Olivotto, I., Sherrid, M. V., Semsarian, C., Autore, C., Ahmed, A. K., Boriani, G., Francia, P., Winters, S. L., et al. (2018) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.117.005820 · Cited by 74
Efficacy of Long Detection Interval Implantable Cardioverter-Defibrillator Settings in Secondary Prevention Population
Kloppe, A., Proclemer, A., Arenal, Á., Lunati, M., Ferrer, J. M., Hersi, A. S., Gułaj, M., WIJFFELS, M. C. E. F., Santi, E., Manotta, L., et al. (2014) · Circulation · doi:10.1161/circulationaha.114.009468 · Cited by 73
Safety and Efficacy of the Subcutaneous Implantable Defibrillator
Lewis, G. F., & Gold, M. R. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.11.026 · Cited by 73
Multidisciplinary team approach to heart failure management
Morton, G., Masters, J., & Cowburn, P. J. (2017) · Heart · doi:10.1136/heartjnl-2016-310598 · Cited by 73
Does ICD Indication Affect Quality of Life and Levels of Distress?
Pedersen, S. S., Sears, S. F., Burg, M. M., & van den Broek, K. C. (2009) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2008.02196.x · Cited by 73
Heart Rhythm Considerations in Heart Transplant Candidates and Considerations for Ventricular Assist Devices: International Society for Heart and Lung Transplantation Guidelines for the Care of Cardiac Transplant Candidates—2006
Gronda, E., Bourge, R. C., Costanzo, M. R., Deng, M. C.-H. K., MANCINI, D. M., Martinelli, L., & Torre‐Amione, G. (2006) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2006.06.005 · Cited by 72

Authors: Bardy, G. H., Lee, K. L., Mark, D. B., Poole, J. E., Packer, D. L., Boineau, R., Domanski, M., Troutman, C., Anderson, J., Johnson, G., McNulty, S. E., Clapp-Channing, N., Davidson-Ray, L. D., Fraulo, E. S., Fishbein, D. P., Luceri, R. M., & Ip, J. H.
Affiliations: The Seattle Institute for Cardiac Research (US)
Duke University (US)
University of Washington (US)
Mayo Clinic (US)
National Heart, Lung, and Blood Institute (US)
ORCID: Lee, Kerry L.
Mark, Daniel B.
Poole, Jeanne E.
Packer, Douglas L.
Boineau, Robin
Davidson-Ray, Linda D.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2005-01-20
Volume: 352
Issue: 3
Pages: 225-237
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmoa043399
OpenAlex: W2075175982
Semantic Scholar: cf04075b17dbae3fc6bc9a3a2f9673f9fad192ea
Cited by: 6,552
References: 20
Citations by year: 2026: 126 · 2025: 170 · 2024: 173 · 2023: 186 · 2022: 231 · 2021: 236 · 2020: 261 · 2019: 285 · 2018: 287 · 2017: 394 · 2016: 326 · 2015: 355 · 2014: 335 · 2013: 369 · 2012: 376
FWCI: 292.60
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Funders: National Heart, Lung, and Blood Institute (UO1 HL55297, UO1 HL55496, UO1 HL55766, U01HL055297, U01HL055766, U01HL055496)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
Keywords: amiodarone, implantable cardioverter-defibrillator, congestive heart failure, sudden cardiac death, mortality, left ventricular ejection fraction, NYHA functional class, antiarrhythmic therapy
MeSH terms: Aged, Amiodarone, Anti-Arrhythmia Agents, Cause of Death, Female, Heart Failure, Humans, Male, Middle Aged, Risk, Stroke Volume, Survival Analysis, Death, Sudden, Cardiac, Defibrillators, Implantable, Cross-Over Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks